(19)
(11) EP 0 853 626 A1

(12)

(43) Date of publication:
22.07.1998 Bulletin 1998/30

(21) Application number: 96928599.0

(22) Date of filing: 30.08.1996
(51) International Patent Classification (IPC): 
A61K 31/ 675( . )
A61P 25/ 00( . )
A61P 25/ 18( . )
A61P 25/ 24( . )
A61P 29/ 00( . )
C07C 213/ 00( . )
C07C 215/ 28( . )
C07C 229/ 38( . )
C07C 255/ 41( . )
C07C 271/ 16( . )
C07F 9/ 30( . )
C07F 9/ 48( . )
C07F 9/ 6533( . )
A61K 31/ 00( . )
A61P 25/ 10( . )
A61P 25/ 22( . )
A61P 25/ 28( . )
A61P 43/ 00( . )
C07C 213/ 02( . )
C07C 229/ 36( . )
C07C 255/ 24( . )
C07C 255/ 42( . )
C07C 271/ 22( . )
C07F 9/ 32( . )
C07F 9/ 572( . )
C07F 9/ 6558( . )
(86) International application number:
PCT/GB1996/002113
(87) International publication number:
WO 1997/009335 (13.03.1997 Gazette 1997/12)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
SI

(30) Priority: 07.09.1995 GB 19950018186
21.06.1996 GB 19960013047

(71) Applicant: Novartis AG
4058 Basel (CH)

(72) Inventors:
  • FRÖSTL, Wolfgang
    CH-4051 Basle (CH)
  • MICKEL, Stuart, John
    CH-4415 Lausen (CH)
  • COOKE, Nigel, Graham
    Sale Cheschire M33 5GS (GB)
  • BENNETT, Stuart, Norman, Lile
    Macclesfield Cheshire SK10 2JA (GB)
  • WILLIAMS, Anne, Rachel, Burton
    Knutsford Cheschire WA16 9AH (GB)

(74) Representative: Bastian, Werner Maria, et al 
Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach
4002 Basel
4002 Basel (CH)

   


(54) SUBSTITUTED PHOSPHINIC COMPOUNDS AND THEIR USE AS PHARMACEUTICALS